Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|14|2170-2177

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2170-2177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinin receptors as targets for cancer therapy

By Figueroa Carlos D   Ehrenfeld Pamela   Bhoola Kanti D  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 299-312

Informa Healthcare

Access to resources Recommend Favorite

Chemokine Receptors as Targets for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 15, Iss. 7, 2009-03 ,pp. : 742-757

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen Receptors as Therapeutic Targets in Breast Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-02 ,pp. : 181-202

Bentham Science Publishers

Access to resources Recommend Favorite

Neurokinin Receptors as Potential Targets in Breast Cancer Treatment

By  

Current Drug Discovery Technologies, Vol. 5, Iss. 1, 2008-03 ,pp. : 15-19

Bentham Science Publishers

Access to resources Recommend Favorite

The Importance of c-Kit and PDGF Receptors as Potential Targets for Molecular Therapy in Breast Cancer

By  

Current Medicinal Chemistry, Vol. 14, Iss. 7, 2007-03 ,pp. : 735-743

Bentham Science Publishers

Access to resources Recommend Favorite